Cambiar Investors LLC decreased its stake in shares of Amdocs Limited (NASDAQ:DOX) by 10.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 642,831 shares of the technology company’s stock after selling 73,325 shares during the period. Cambiar Investors LLC owned about 0.44% of Amdocs Limited worth $41,347,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. BB&T Investment Services Inc. bought a new position in Amdocs Limited during the second quarter valued at approximately $118,000. Acrospire Investment Management LLC bought a new position in Amdocs Limited during the second quarter valued at approximately $155,000. Robecosam AG lifted its position in Amdocs Limited by 37.8% during the second quarter. Robecosam AG now owns 2,550 shares of the technology company’s stock valued at $163,000 after purchasing an additional 700 shares during the period. Atria Investments LLC bought a new position in Amdocs Limited during the second quarter valued at approximately $218,000. Finally, Sawtooth Solutions LLC bought a new position in Amdocs Limited during the second quarter valued at approximately $220,000. Institutional investors own 90.88% of the company’s stock.
Shares of Amdocs Limited (NASDAQ DOX) traded up $0.52 during midday trading on Monday, hitting $62.52. 2,153,800 shares of the stock were exchanged, compared to its average volume of 679,689. The stock has a market capitalization of $9,087.60, a PE ratio of 17.66, a PEG ratio of 2.22 and a beta of 0.53. Amdocs Limited has a 1 year low of $56.10 and a 1 year high of $67.98.
Amdocs Limited (NASDAQ:DOX) last announced its quarterly earnings data on Wednesday, November 8th. The technology company reported $0.94 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.89 by $0.05. The firm had revenue of $979.70 million during the quarter, compared to analysts’ expectations of $977.72 million. Amdocs Limited had a net margin of 11.30% and a return on equity of 14.77%. The company’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.89 earnings per share. analysts forecast that Amdocs Limited will post 3.67 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 19th. Stockholders of record on Friday, December 29th will be paid a $0.22 dividend. The ex-dividend date is Thursday, December 28th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.41%. Amdocs Limited’s dividend payout ratio (DPR) is presently 29.73%.
Amdocs Limited announced that its Board of Directors has initiated a share buyback program on Wednesday, November 8th that permits the company to repurchase $800.00 million in shares. This repurchase authorization permits the technology company to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.
COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.chaffeybreeze.com/2017/11/13/cambiar-investors-llc-has-41-35-million-stake-in-amdocs-limited-dox.html.
Several research analysts have weighed in on DOX shares. Robert W. Baird reiterated a “hold” rating and issued a $66.00 price target on shares of Amdocs Limited in a research report on Friday, October 20th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and issued a $77.00 price target on shares of Amdocs Limited in a research report on Wednesday, September 27th. Stifel Nicolaus reiterated a “buy” rating and issued a $72.00 price target (up from $68.00) on shares of Amdocs Limited in a research report on Thursday, August 3rd. BidaskClub upgraded shares of Amdocs Limited from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 26th. Finally, Zacks Investment Research upgraded shares of Amdocs Limited from a “hold” rating to a “buy” rating and set a $71.00 price target on the stock in a research report on Friday. One analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $70.29.
Amdocs Limited Company Profile
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related companies with MarketBeat.com's FREE daily email newsletter.